The clinical study evaluates the safety and efficacy of MIRA, the company’s miniaturized robotic-assisted surgery (miniRAS) device. A minimally invasive robot could shorten hospital stays and reduce blood loss. It could also decrease complication rates compared to open surgery for benign hysterectomy, the company said in a news release.

Virtual Incision’s MIRA system features a small, self-contained surgical device. Inserted through a single midline umbilical incision in the patient’s abdomen, it allows for complex, multi-quadrant abdominal surgeries. The system also uses existing minimally invasive tools and techniques that are familiar to surgeons. Altogether, MIRA weighs about two pounds.